Laboratory Biosafety Guidance Related to the Novel Coronavirus (2019-nCoV) [12 February 2020] [open pdf - 0B]
From the Introduction: "The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patient that meet the case definition of the novel pathogen identified in Wuhan, China, i.e. 2019 novel coronavirus (2019-nCoV), the disease named COVID-19. As our understanding of the disease caused by 2019-nCoV is limited but rapidly growing, WHO [World Health Organization] continues to monitor developments and will revise these recommendations as necessary."
WHO reference number: WHO/WPE/GIH/2020.1
2020 World Health Organization
World Health Organization: https://who.int/